menu search

Inozyme pharma announces three poster presentations at the american society for bone and mineral research (asbmr) 2023 annual meeting

BOSTON, Oct. 06, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY) (“Inozyme” or the “Company”), a clinical-stage rare disease bio...

October 6, 2023, 12:30 pm

Investor alert: 3 fintech stocks ready to roar

In the vivid landscape of investment opportunities, zeroing in on fintech stocks to buy will always remain relevant. The fintech sphere effectively me...

October 6, 2023, 8:42 am

Infinity pharmaceuticals, inc. investors: lead plaintiff deadline is approaching in the class action against infinity pharmaceuticals, inc.; contact robbins llp today

SAN DIEGO, Oct. 05, 2023 (GLOBE NEWSWIRE) — Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons and entities ...

October 5, 2023, 7:18 pm

Miromatrix ceo jeff ross to present at the 2023 cell & gene meeting on the mesa

EDEN PRAIRIE, Minn., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a ...

October 5, 2023, 4:30 pm

Neurona therapeutics announces publication in cell stem cell reporting the development of investigational novel regenerative cell therapy strategy for drug-resistant focal epilepsy

Publication demonstrates robust and reproducible generation of pure pallial, medial ganglionic eminence (MGE)-type GABAergic inhibitory interneuron ce...

October 5, 2023, 3:00 pm

Verastem: signs of life for a beaten-down equity

Verastem is a biotechnology company focused on developing novel agents for solid tumors, with its main ...

October 4, 2023, 9:00 pm

Pharvaris to present at the ciic fall 2023 conference

ZUG, Switzerland, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin-B2-receptor a...

October 4, 2023, 7:34 am

Io biotech announces three poster presentations at the society for immunotherapy of cancer’s (sitc) 38th annual meeting

NEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) — IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating...

October 3, 2023, 8:30 pm

Road to riches: 3 ev stocks poised to supercharge your portfolio

The automotive landscape is undergoing a tectonic shift in an era when the rumble of engines is slowly giving way to the silent hum of electric motors...

October 3, 2023, 3:33 pm

Acumen pharmaceuticals: novel alzheimer's molecule with positive early data

Acumen Pharmaceuticals is developing a monoclonal antibody, ACU193, that targets Amyloid beta oligomers (AβOs) in Alzheimer's disease. AβOs are smal...

October 3, 2023, 5:15 am

Verona pharma to present additional analyses of positive phase 3 enhance studies in copd at chest 2023

PDUFA Target Action Date of June 26, 2024 Pooled analysis and subgroup data further support potential of ensifentrine,  an investigational, novel, se...

October 3, 2023, 2:00 am

$vktx: consolidation in viking therapeutics provides an opportunity

Viking Therapeutics Inc. is an innovative biotechnology company developing novel therapeutics for metab...

October 2, 2023, 6:17 pm

Wsj says ackman has indicted he'd be happy to take twitter public - adds chances not great

The Wall Street Journal reported over the weekend on Bill Ackman's firm, Pershing Square, having received regulatory signoff Friday for a ...

October 1, 2023, 9:20 pm

Zuckerberg's new metaverse tech leaves lex fridman speechless

When Facebook founder and Meta Platforms Inc (NASDAQ:FB) head Mark Zuckerberg met up with podcaster Lex Fridman for a virtual video podcast on Thursda...

September 29, 2023, 7:01 am

Modex therapeutics secures barda contract to develop novel multispecific antibodies against viral infectious disease threats

Provides Initial $59 Million and up to $168 Million Contingent on Milestones NATICK, Mass., Sept. 28, 2023 (GLOBE NEWSWIRE) — ModeX Therapeutics Inc...

September 28, 2023, 8:08 pm

Onconova therapeutics to present a late-breaking abstract on rigosertib at the 2023 eadv congress

NEWTOWN, Pa., Sept. 28, 2023 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”, the “Company”), a clinical-stage bi...

September 28, 2023, 12:00 pm

Don't miss the boom: 3 cannabis stocks set to explode higher

Navigating the ever-evolving investment landscape, one can't help but be drawn to the captivating narrative surrounding cannabis stocks. The allure is...

September 28, 2023, 11:28 am

Ionis (ions) inks new deal with roche to develop novel rna drugs

Per the agreement, Ionis (IONS) will grant exclusive global rights to Roche to develop and market two novel ...

September 28, 2023, 11:17 am

Kineta announces participation at october investor conferences

SEATTLE, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of ...

September 28, 2023, 9:30 am

Sagimet biosciences announces completion of enrollment of 120 patients for phase 3 clinical trial by its partner ascletis of denifanstat combined with bevacizumab for treatment of recurrent glioblasto

SAN MATEO, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing ...

September 27, 2023, 8:05 pm


Search within

Pages Search Results: